Search
Estring
Indications:
-> atrophic vaginitis
Dosage: releases 7.5 ug/day of estradiol
Adverse effects:
-> little to no systemic effects
-> no need for progestin to prevent endometrial hyperplasia
Mechanism of action:
-> vaginal ring that releases estradiol over 90 days
Related
Femring
General
vaginal ring
hormone replacement therapy (HRT); estrogen replacement therapy; postmenopausal hormone replacement therapy
References
Prescriber's Letter 10(5):27 2003
Components
17-beta estradiol (E2, Estrace, Estinyl, Delestrogen, Elestrin, Evamist, Imvexxy)